Status:

COMPLETED

Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias

Lead Sponsor:

St. Jude Children's Research Hospital

Conditions:

Anemia, Aplastic

Amegakaryocytic Thrombocytopenia

Eligibility:

All Genders

Up to 21 years

Phase:

NA

Brief Summary

Due to an overall and disease free survival of 85% to 100%, allogeneic blood or bone marrow stem cell transplantation using an HLA matched sibling donor is the therapy of choice for patients with seve...

Detailed Description

Secondary objectives for this protocol include the following: * To observe the degree of hematopoietic chimerism in T-cells during the first year posttransplant. * To observe the relative proportions...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • One of the following diagnoses:
  • Refractory severe aplastic anemia
  • Refractory Kostmann syndrome
  • Refractory Diamond-Blackfan anemia
  • Refractory amegakaryocytic thrombocytopenia
  • Absence of a suitable HLA-matched sibling donor and absence of a 10/10 allele matched unrelated donor.
  • Life expectancy of greater than six weeks as per the judgment of the principal investigator.
  • Karnofsky or Lansky Performance Status score of greater than or equal to 70%.
  • Creatinine clearance is greater than or equal to 40 cc/min/1.73 m2.
  • FVC greater than or equal to 40% of predicted or pulse oximetry greater than or equal to 92% on room air.
  • Does not have a known allergy to murine products.
  • Exclusion criteria:
  • Ejection fraction or shortening fraction below the lower limit of normal for age.
  • Lactating (female patient).
  • Pregnant or lactating
  • Diagnosis of Fanconi Anemia.
  • Positive HLA crossmatch with donor

Exclusion

    Key Trial Info

    Start Date :

    October 1 2005

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    February 1 2009

    Estimated Enrollment :

    4 Patients enrolled

    Trial Details

    Trial ID

    NCT00244010

    Start Date

    October 1 2005

    End Date

    February 1 2009

    Last Update

    May 30 2017

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    St. Jude Children's Research Hospital

    Memphis, Tennessee, United States, 38105

    Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias | DecenTrialz